Pay no more than $25,* with a maximum benefit of $100, on your APRISO prescription
Pay the initial $25 and receive up to $100 off your out-of-pocket expense
With APRISO, we can not only help maintain remission of ulcerative colitis (UC), but we can also help you maintain your budget. Ulcerative colitis can be a challenging condition to keep under control, but money should never come between a patient with UC and maintaining remission.
If you have already received an APRISO Savings Card from your healthcare provider, all you have to do is activate it.
If you don't have an APRISO Savings Card yet, you can start saving in 4 simple steps:
- Get an APRISO Savings Card
- Make sure you have an APRISO prescription—if you do not, talk to your healthcare provider about whether APRISO may be right for you
- Take your APRISO Savings Card to the pharmacy when you fill your prescription
- Keep this card in order to receive a discount each month on your APRISO prescription
Note—If you download your APRISO Savings Card here, it is automatically activated, and there is no need to go through the activation process.
If you live in Massachusetts, or if your prescription plan is paid/partially paid by Medicaid, Medicare, or federal or state government programs, this coupon offer is not available to you.
With this card, you will pay the first $25 of your co-pay or retail cost and receive up to $100 off your out-of-pocket expense.* This card is valid for 1 use per month until December 31, 2012.
*You will be required to pay a minimum of $25 of your co-pay or retail cost. You could pay more than $25 if your co-pay or retail cost exceeds $125. Not valid in Massachusetts. Void where prohibited by law. This offer is not valid for prescriptions reimbursed in whole or in part by Medicaid, Medicare, or federally or state-funded programs.
IMPORTANT SAFETY INFORMATION
APRISO is a locally acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis in patients 18 years and older. APRISO is contraindicated in patients with hypersensitivity to salicylates or aminosalicylates (sulfasalazine) or to any of the components of APRISO capsules. It is recommended that patients have an evaluation of renal function prior to initiation of APRISO therapy and periodically while on therapy. Exercise caution when using APRISO in patients with known renal dysfunction or a history of renal disease. Mesalamine has been associated with an acute intolerance syndrome that may be difficult to distinguish from a flare of inflammatory bowel disease. Symptoms include cramping, acute abdominal pain and bloody diarrhea, sometimes fever, headache, and rash. If acute intolerance syndrome is suspected, promptly discontinue treatment with APRISO. There have been reports of hepatic failure in patients with pre-existing liver disease who have been administered mesalamine. Caution should be exercised when administering APRISO to patients with liver disease. The recommended dose of APRISO is four 0.375-g capsules once daily in the morning (1.5 g/day) with or without food. Because dissolution of the coating of APRISO granules depends on pH, APRISO should not be coadministered with antacids. Patients with phenylketonuria should be aware that APRISO contains aspartame, equivalent to 2.24 mg of phenylalanine per day. In 2 well-controlled clinical trials, the most common treatment-related adverse events occurring in at least 3% of adult patients taking 1.5 g/day of APRISO and at a rate greater than placebo were headache (11% vs 8% for placebo), diarrhea (8% vs 7% for placebo), upper abdominal pain (5% vs 3% for placebo), nausea (4% vs 3% for placebo), nasopharyngitis (4% vs 3% for placebo), influenza and influenza-like illness (4% vs 4% for placebo), and sinusitis (3% vs 3% for placebo).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch/ or call
1-800-FDA-1088.
Complete Prescribing Information
For product information, adverse event reports, and product complaint reports, please contact:
Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183
E-mail: Salix@medcomsol.com